CooperCompanies reported Q1 2025 revenue of $964.7 million, a 4% increase year-over-year. The company saw growth across its divisions, with CooperVision revenue up 4% to $646.1 million and CooperSurgical revenue up 3% to $318.6 million. GAAP net income reached $104.3 million, translating to diluted EPS of $0.52, while non-GAAP EPS came in at $0.92. Operating income was $182.0 million, with a 19% operating margin. Free cash flow stood at $101.2 million, driven by strong operational performance.
Total revenue increased 4% year-over-year to $964.7 million.
CooperVision revenue grew 4%, while CooperSurgical revenue rose 3%.
GAAP EPS was $0.52, and non-GAAP EPS increased to $0.92.
Free cash flow reached $101.2 million, reflecting strong cash generation.
CooperCompanies expects continued revenue growth in fiscal 2025, with an updated EPS outlook.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance